RNAC
Cartesian Therapeutics Inc.
$8.52
+$0.07(+0.83%)
48
Overall
40
Value
54
Tech
52
Quality
Market Cap
$205.43M
Volume
173.66K
52W Range
$5.98 - $26.20
Target Price
$35.29
Company Overview
| Mkt Cap | $205.43M | Price | $8.52 |
| Volume | 173.66K | Change | +0.83% |
| P/E Ratio | -2.7 | Open | $8.44 |
| Revenue | $38.3M | Prev Close | $8.45 |
| Net Income | $-77.4M | 52W Range | $5.98 - $26.20 |
| Div Yield | N/A | Target | $35.29 |
| Overall | 48 | Value | 40 |
| Quality | 52 | Technical | 54 |
No chart data available
Latest News
Analysts Offer Insights on Healthcare Companies: Cartesian Therapeutics (RNAC) and Galmed Pharmaceuticals (GLMD)
Brian Anderson•25 days ago
Wedbush Remains a Buy on Cartesian Therapeutics (RNAC)
TipRanks Auto-Generated Intelligence Newsdesk•a month ago
Cantor Fitzgerald Sticks to Its Hold Rating for Cartesian Therapeutics (RNAC)
TipRanks Auto-Generated Intelligence Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $8.52 | +0.8% | 173.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW